First report of Neisseria meningitidis intermediately resistant to penicillin in Croatia
Neisseria meningitidis is one of the leading causes of bacterial meningitis and sepsis in Croatia. Meningococcal strains with decreased susceptibility to penicillin (MIC > 0.12 mg/ml) have been reported worldwide since 1985. Here we report the first identification of an isolate intermediately res...
Gespeichert in:
Veröffentlicht in: | Journal of clinical microbiology 2001-02, Vol.39 (2), p.823-823 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 823 |
---|---|
container_issue | 2 |
container_start_page | 823 |
container_title | Journal of clinical microbiology |
container_volume | 39 |
creator | Boras, A Bozinovic, D Tenover, F C Popovic, T |
description | Neisseria meningitidis is one of the leading causes of bacterial meningitis and sepsis in Croatia. Meningococcal strains with decreased susceptibility to penicillin (MIC > 0.12 mg/ml) have been reported worldwide since 1985. Here we report the first identification of an isolate intermediately resistant to penicillin in Croatia. An 8-month-old male child presented to the Emergency Department at University Hospital for Infectious Diseases, Zagreb, Croatia, with a 2-day history of fever (>39 degree C). The child was somnolent, with characteristic meningeal signs and petechia on its scrotum and entire extremities. The white blood cell count was 5,800/mm super(3), with 51 segmented neutrophils and 32 lymphocytes. The cerebrospinal fluid (CSF) contained 92,416 cells/mm super(3), the protein concentration was 2,040 mg/liter, and the glucose concentration was 0.3 mmol/liter. Gram-negative diplococci were visible on a Gram-stained smear, and latex agglutination performed on the CSF was positive for N. meningitidis serogroup B (Slidex meningite-Kit 5; bioMerieux, Marcy-l'Etoile, France). Ceftriaxone therapy was instituted, and household contacts were treated with rifampin. |
doi_str_mv | 10.1128/JCM.39.2.823.2001 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_87832</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17809995</sourcerecordid><originalsourceid>FETCH-LOGICAL-c393t-957a218454157f1628a1c5f451ec4a96ab939f8d954e48cb107835da125dd1773</originalsourceid><addsrcrecordid>eNpVkU1LAzEQhoMotlZ_gBfZk7ddM8mmm4AXKdYPql4UegvpbraObDc1SQX_vSkWPw5DDvM8k2FeQk6BFgBMXtxPHgquClZIxgtGKeyRIVAl8_GYzvfJkFIlcgBeDchRCG8JKEshDslga6eiQzKfog8x83btfMxcmz1aDMF6NNnK9tgvMWKDIcM-Wr-yDZpou8_EBwzR9DGLLlsnsMauwz5h2cQ7E9Eck4PWdMGe7N4ReZleP09u89nTzd3kapbXXPGYK1EZBrIUJYiqhTGTBmrRlgJsXRo1NgvFVSsbJUpbynoBtJJcNAaYaBqoKj4il99z15tF2q-2ffSm02uPK-M_tTOo_3d6fNVL96FlGsSSfr7TvXvf2BD1CkNtu8701m2ChkpSpZRIIHyDtXcheNv-fAFUb--pUxqaK810SkNv00jO2d_dfo3d-fkXWH-H2w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17809995</pqid></control><display><type>article</type><title>First report of Neisseria meningitidis intermediately resistant to penicillin in Croatia</title><source>American Society for Microbiology</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Boras, A ; Bozinovic, D ; Tenover, F C ; Popovic, T</creator><creatorcontrib>Boras, A ; Bozinovic, D ; Tenover, F C ; Popovic, T</creatorcontrib><description>Neisseria meningitidis is one of the leading causes of bacterial meningitis and sepsis in Croatia. Meningococcal strains with decreased susceptibility to penicillin (MIC > 0.12 mg/ml) have been reported worldwide since 1985. Here we report the first identification of an isolate intermediately resistant to penicillin in Croatia. An 8-month-old male child presented to the Emergency Department at University Hospital for Infectious Diseases, Zagreb, Croatia, with a 2-day history of fever (>39 degree C). The child was somnolent, with characteristic meningeal signs and petechia on its scrotum and entire extremities. The white blood cell count was 5,800/mm super(3), with 51 segmented neutrophils and 32 lymphocytes. The cerebrospinal fluid (CSF) contained 92,416 cells/mm super(3), the protein concentration was 2,040 mg/liter, and the glucose concentration was 0.3 mmol/liter. Gram-negative diplococci were visible on a Gram-stained smear, and latex agglutination performed on the CSF was positive for N. meningitidis serogroup B (Slidex meningite-Kit 5; bioMerieux, Marcy-l'Etoile, France). Ceftriaxone therapy was instituted, and household contacts were treated with rifampin.</description><identifier>ISSN: 0095-1137</identifier><identifier>EISSN: 1098-660X</identifier><identifier>DOI: 10.1128/JCM.39.2.823.2001</identifier><identifier>PMID: 11281120</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>ceftriaxone ; Ceftriaxone - therapeutic use ; Cephalosporins - therapeutic use ; Cortisone - therapeutic use ; Croatia ; Humans ; Infant ; Letters to the Editor ; Male ; Meningitis, Meningococcal - diagnosis ; Meningitis, Meningococcal - drug therapy ; Microbial Sensitivity Tests ; Neisseria meningitidis ; Neisseria meningitidis - classification ; Neisseria meningitidis - drug effects ; Neisseria meningitidis - isolation & purification ; penicillin ; Penicillin Resistance ; rifampin ; Treatment Outcome</subject><ispartof>Journal of clinical microbiology, 2001-02, Vol.39 (2), p.823-823</ispartof><rights>Copyright © 2001, American Society for Microbiology 2001</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c393t-957a218454157f1628a1c5f451ec4a96ab939f8d954e48cb107835da125dd1773</citedby><cites>FETCH-LOGICAL-c393t-957a218454157f1628a1c5f451ec4a96ab939f8d954e48cb107835da125dd1773</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC87832/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC87832/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,3186,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11281120$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boras, A</creatorcontrib><creatorcontrib>Bozinovic, D</creatorcontrib><creatorcontrib>Tenover, F C</creatorcontrib><creatorcontrib>Popovic, T</creatorcontrib><title>First report of Neisseria meningitidis intermediately resistant to penicillin in Croatia</title><title>Journal of clinical microbiology</title><addtitle>J Clin Microbiol</addtitle><description>Neisseria meningitidis is one of the leading causes of bacterial meningitis and sepsis in Croatia. Meningococcal strains with decreased susceptibility to penicillin (MIC > 0.12 mg/ml) have been reported worldwide since 1985. Here we report the first identification of an isolate intermediately resistant to penicillin in Croatia. An 8-month-old male child presented to the Emergency Department at University Hospital for Infectious Diseases, Zagreb, Croatia, with a 2-day history of fever (>39 degree C). The child was somnolent, with characteristic meningeal signs and petechia on its scrotum and entire extremities. The white blood cell count was 5,800/mm super(3), with 51 segmented neutrophils and 32 lymphocytes. The cerebrospinal fluid (CSF) contained 92,416 cells/mm super(3), the protein concentration was 2,040 mg/liter, and the glucose concentration was 0.3 mmol/liter. Gram-negative diplococci were visible on a Gram-stained smear, and latex agglutination performed on the CSF was positive for N. meningitidis serogroup B (Slidex meningite-Kit 5; bioMerieux, Marcy-l'Etoile, France). Ceftriaxone therapy was instituted, and household contacts were treated with rifampin.</description><subject>ceftriaxone</subject><subject>Ceftriaxone - therapeutic use</subject><subject>Cephalosporins - therapeutic use</subject><subject>Cortisone - therapeutic use</subject><subject>Croatia</subject><subject>Humans</subject><subject>Infant</subject><subject>Letters to the Editor</subject><subject>Male</subject><subject>Meningitis, Meningococcal - diagnosis</subject><subject>Meningitis, Meningococcal - drug therapy</subject><subject>Microbial Sensitivity Tests</subject><subject>Neisseria meningitidis</subject><subject>Neisseria meningitidis - classification</subject><subject>Neisseria meningitidis - drug effects</subject><subject>Neisseria meningitidis - isolation & purification</subject><subject>penicillin</subject><subject>Penicillin Resistance</subject><subject>rifampin</subject><subject>Treatment Outcome</subject><issn>0095-1137</issn><issn>1098-660X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkU1LAzEQhoMotlZ_gBfZk7ddM8mmm4AXKdYPql4UegvpbraObDc1SQX_vSkWPw5DDvM8k2FeQk6BFgBMXtxPHgquClZIxgtGKeyRIVAl8_GYzvfJkFIlcgBeDchRCG8JKEshDslga6eiQzKfog8x83btfMxcmz1aDMF6NNnK9tgvMWKDIcM-Wr-yDZpou8_EBwzR9DGLLlsnsMauwz5h2cQ7E9Eck4PWdMGe7N4ReZleP09u89nTzd3kapbXXPGYK1EZBrIUJYiqhTGTBmrRlgJsXRo1NgvFVSsbJUpbynoBtJJcNAaYaBqoKj4il99z15tF2q-2ffSm02uPK-M_tTOo_3d6fNVL96FlGsSSfr7TvXvf2BD1CkNtu8701m2ChkpSpZRIIHyDtXcheNv-fAFUb--pUxqaK810SkNv00jO2d_dfo3d-fkXWH-H2w</recordid><startdate>20010201</startdate><enddate>20010201</enddate><creator>Boras, A</creator><creator>Bozinovic, D</creator><creator>Tenover, F C</creator><creator>Popovic, T</creator><general>American Society for Microbiology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>5PM</scope></search><sort><creationdate>20010201</creationdate><title>First report of Neisseria meningitidis intermediately resistant to penicillin in Croatia</title><author>Boras, A ; Bozinovic, D ; Tenover, F C ; Popovic, T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c393t-957a218454157f1628a1c5f451ec4a96ab939f8d954e48cb107835da125dd1773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>ceftriaxone</topic><topic>Ceftriaxone - therapeutic use</topic><topic>Cephalosporins - therapeutic use</topic><topic>Cortisone - therapeutic use</topic><topic>Croatia</topic><topic>Humans</topic><topic>Infant</topic><topic>Letters to the Editor</topic><topic>Male</topic><topic>Meningitis, Meningococcal - diagnosis</topic><topic>Meningitis, Meningococcal - drug therapy</topic><topic>Microbial Sensitivity Tests</topic><topic>Neisseria meningitidis</topic><topic>Neisseria meningitidis - classification</topic><topic>Neisseria meningitidis - drug effects</topic><topic>Neisseria meningitidis - isolation & purification</topic><topic>penicillin</topic><topic>Penicillin Resistance</topic><topic>rifampin</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boras, A</creatorcontrib><creatorcontrib>Bozinovic, D</creatorcontrib><creatorcontrib>Tenover, F C</creatorcontrib><creatorcontrib>Popovic, T</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boras, A</au><au>Bozinovic, D</au><au>Tenover, F C</au><au>Popovic, T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>First report of Neisseria meningitidis intermediately resistant to penicillin in Croatia</atitle><jtitle>Journal of clinical microbiology</jtitle><addtitle>J Clin Microbiol</addtitle><date>2001-02-01</date><risdate>2001</risdate><volume>39</volume><issue>2</issue><spage>823</spage><epage>823</epage><pages>823-823</pages><issn>0095-1137</issn><eissn>1098-660X</eissn><abstract>Neisseria meningitidis is one of the leading causes of bacterial meningitis and sepsis in Croatia. Meningococcal strains with decreased susceptibility to penicillin (MIC > 0.12 mg/ml) have been reported worldwide since 1985. Here we report the first identification of an isolate intermediately resistant to penicillin in Croatia. An 8-month-old male child presented to the Emergency Department at University Hospital for Infectious Diseases, Zagreb, Croatia, with a 2-day history of fever (>39 degree C). The child was somnolent, with characteristic meningeal signs and petechia on its scrotum and entire extremities. The white blood cell count was 5,800/mm super(3), with 51 segmented neutrophils and 32 lymphocytes. The cerebrospinal fluid (CSF) contained 92,416 cells/mm super(3), the protein concentration was 2,040 mg/liter, and the glucose concentration was 0.3 mmol/liter. Gram-negative diplococci were visible on a Gram-stained smear, and latex agglutination performed on the CSF was positive for N. meningitidis serogroup B (Slidex meningite-Kit 5; bioMerieux, Marcy-l'Etoile, France). Ceftriaxone therapy was instituted, and household contacts were treated with rifampin.</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>11281120</pmid><doi>10.1128/JCM.39.2.823.2001</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0095-1137 |
ispartof | Journal of clinical microbiology, 2001-02, Vol.39 (2), p.823-823 |
issn | 0095-1137 1098-660X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_87832 |
source | American Society for Microbiology; MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | ceftriaxone Ceftriaxone - therapeutic use Cephalosporins - therapeutic use Cortisone - therapeutic use Croatia Humans Infant Letters to the Editor Male Meningitis, Meningococcal - diagnosis Meningitis, Meningococcal - drug therapy Microbial Sensitivity Tests Neisseria meningitidis Neisseria meningitidis - classification Neisseria meningitidis - drug effects Neisseria meningitidis - isolation & purification penicillin Penicillin Resistance rifampin Treatment Outcome |
title | First report of Neisseria meningitidis intermediately resistant to penicillin in Croatia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T02%3A04%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=First%20report%20of%20Neisseria%20meningitidis%20intermediately%20resistant%20to%20penicillin%20in%20Croatia&rft.jtitle=Journal%20of%20clinical%20microbiology&rft.au=Boras,%20A&rft.date=2001-02-01&rft.volume=39&rft.issue=2&rft.spage=823&rft.epage=823&rft.pages=823-823&rft.issn=0095-1137&rft.eissn=1098-660X&rft_id=info:doi/10.1128/JCM.39.2.823.2001&rft_dat=%3Cproquest_pubme%3E17809995%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17809995&rft_id=info:pmid/11281120&rfr_iscdi=true |